Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиEnveric Biosciences Мультипликаторы 2011-2024 | ENVB
Мультипликаторы по годам Enveric Biosciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.0 | -0.3 | - | - | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-13 | -103.7 | -1.2 | -2.8 | -20.5 | -0.8 | -0.2 | -0.1 | 6.3 | - | - | - |
EV (Enterprise Value) |
-11.4 млн | -12.6 млн | 1.07 млн | 14 млн | 17.5 млн | 27.9 млн | 26.5 млн | 11.7 млн | 3.87 тыс. | 24.4 тыс. | 24.3 тыс. | -336 |
EBITDA per Share |
-18.7 | -135 | -11.8 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
0.2 | -0.1 | - | - | - | - | - | - | - | - | - | |
PEG |
- | -0.0 | - | - | - | - | - | - | - | - | - | |
P/B |
0.2 | 0.0 | 0.6 | - | - | - | - | - | - | - | - | - |
P/CF |
-0.1 | -0.0 | -0.5 | - | - | - | - | - | - | - | - | - |
ROE % |
-125.90 | -219.57 | -200.98 | - | - | - | - | - | - | - | - | - |
ROA % |
-94.47 | -183.30 | -167.56 | - | - | - | - | - | - | - | - | - |
ROCE % |
- | -269.47 | -164.46 | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.9 | 6.1 | 3.3 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Enveric Biosciences
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.3 | -3.04 | -2.31 | - | -1.46 | -2.73 | -5.34 | - | -5.91 | -2.13 | -0.2 | - | -0.2 | -0.48 | -0.6 | - | -0.03 | -0.67 | -1.09 | - | 0.18 | -0.07 | -0.11 | - | -0.31 | -0.26 | -0.09 | - | -0.13 | -0.09 | -0.09 | - | -0.02 | 0.01 | 0.11 | - | - | 0.04 | 0.04 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.55 | -2.69 | -2.3 | - | -3.12 | -4.39 | -5.58 | - | -7.28 | -7.47 | -0.41 | - | 0.01 | -0.07 | -0.05 | - | -0.47 | -0.45 | -0.41 | - | 0.31 | -0.01 | -0.03 | - | -0.21 | -0.18 | - | - | -0.06 | -0.07 | -0.07 | - | -0.03 | 0.02 | 0.11 | - | - | 0.06 | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-302.07 | -197.05 | -79.36 | -42.07 | -46.97 | -41.01 | -33.13 | -26.84 | -43.39 | -55.05 | -74.18 | -72.67 | -125.49 | -161.75 | -190.60 | -123.14 | -70.17 | 35.62 | 76.72 | 26.65 | -6.64 | -92.90 | -105.26 | -62.25 | -99.66 | -103.77 | -90.06 | -57.72 | -119.43 | -143.74 | -90.45 | 397.67 | 351.11 | 366.27 | 4405.36 | 4131.65 | 4154.17 | 4223.26 | 160.49 | 65.00 | 89.25 | 90.97 | 92.07 | 64.75 | -16.19 | -121.39 | -221.47 | -404.02 | -80.94 | -79.74 | -243.34 |
ROA % |
-145.03 | -110.43 | -55.34 | -31.86 | -35.75 | -31.60 | -25.67 | -20.33 | -34.13 | -44.04 | -60.18 | -60.59 | -82.76 | -91.13 | -93.33 | -51.78 | -32.55 | 8.85 | 26.77 | 9.68 | 1.88 | -25.14 | -27.17 | -15.46 | -19.96 | -16.66 | -13.44 | -10.50 | -11.65 | -8.30 | -4.44 | 7.43 | -27.39 | -61.06 | 3339.48 | 3378.39 | 3276.39 | 3209.22 | -279.22 | -294.25 | -381.14 | -366.04 | -351.83 | -232.02 | -248.44 | -177.97 | -121.26 | -81.97 | -16.42 | -16.18 | -49.37 |
ROCE % |
-20.57 | -41.15 | -59.53 | -54.89 | -61.25 | -47.02 | -46.51 | -59.84 | -71.39 | -76.59 | -73.27 | -50.60 | -60.99 | -59.82 | -57.79 | -31.42 | 9.39 | 60.59 | 65.89 | 24.44 | -2.58 | -70.41 | -85.12 | -52.63 | -59.12 | -38.59 | -20.16 | -13.65 | -135.79 | -251.43 | -178.32 | 363.93 | 318.33 | 394.86 | 6074.68 | 5839.30 | 5861.83 | 5929.96 | 199.78 | 65.00 | 87.75 | 87.98 | 89.08 | 63.26 | -17.69 | -121.39 | -221.47 | -404.02 | -80.94 | -79.74 | -243.34 |
Current Ratio |
- | - | - | - | 4.2 | 4.8 | 4.2 | 6.0 | 4.8 | 4.9 | 3.8 | 6.0 | 6.0 | 6.0 | 6.0 | 0.1 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 1.0 | 1.0 | 1.0 | 1.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | 79.9 | 85.1 | 68.8 | - | 69.8 | 52.9 | 60.9 | - | 67.9 | 64.8 | 68.9 | - | 64.4 | 65.7 | 62.5 | - | 73.1 | 110.0 | 84.1 | - | 99.6 | 113.1 | 51.9 | - | - | 33.6 | 33.6 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | 65.3 | 71.7 | 58.8 | - | 59.2 | 49.6 | 48.4 | - | 48.5 | 46.0 | 50.8 | - | 48.8 | 48.9 | 52.8 | - | 56.0 | 90.6 | 65.7 | - | 78.4 | 80.4 | 37.6 | - | - | 43.9 | 44.2 | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | 79.9 | 85.1 | 68.8 | - | 69.8 | 52.9 | 60.9 | - | 67.9 | 64.8 | 68.9 | - | 64.4 | 65.7 | 62.5 | - | 73.1 | 110.0 | 84.1 | - | 99.6 | 113.1 | 51.9 | - | - | 33.6 | 33.6 | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | 14.6 | 13.4 | 10.0 | - | 10.6 | 3.2 | 12.4 | - | 19.4 | 18.9 | 18.1 | - | 15.6 | 16.8 | 9.7 | - | 17.1 | 19.4 | 18.4 | - | 21.2 | 32.7 | 14.3 | - | - | -10.4 | -10.7 | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD